ArticleAmerican journal of ophthalmology2020
Pseudostrabismus in the First Year of Life and the Subsequent Diagnosis of Strabismus.
Article in American journal of ophthalmology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed, 4 citations in OpenAlex.
- Identification of OCTA Biomarkers and Cutoff Values Associated with Disease Severity in Dry Age-Related Macular Degeneration.Ophthalmology and therapy · 2026Article
- FEVR combined with macular heterotopia in children presenting as pseudo-exotropia: a case report and literature review.Frontiers in medicine · 2024Article
- Screening, Diagnosis, and Treatment of Pediatric Ocular Diseases.Children (Basel, Switzerland) · 2022Review
- Presence and development of strabismus in children with telecanthus, epicanthus and hypertelorism.Indian journal of ophthalmology · 2022Observational
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 3 institutions in 1 country.
Funding
Abstract
purposeTo report the population-based birth prevalence of pseudostrabismus in the first year of life and the subsequent diagnosis of strabismus.
designRetrospective population-based cohort study.
methodsAll residents of Olmsted County, Minnesota ≤1 year old diagnosed with pseudostrabismus from January 1, 2005 through December 31, 2014, were identified using a medical record linkage system that captures virtually all medical care provided in a single Midwestern United States county population. The birth prevalence of pseudostrabismus and the subsequent diagnosis of strabismus were assessed.
resultsA total of 184 infants were diagnosed with pseudostrabismus during the 10-year study period, which yielded a birth prevalence of 1 in 113 children in the first year of life. There were 165 (89.7%) infants initially diagnosed by a non-ophthalmology care provider (NOCP) and confirmed by an ophthalmologist, 13 (7.1%) patients were diagnosed by an ophthalmologist alone, and 6 (3.3%) patients were diagnosed by a NOCP alone. Eighty-eight (49.4%) infants had at least 1 follow-up visit with an ophthalmologist, and the median follow-up time from pseudostrabismus diagnosis to the last health care visit that included an eye examination was 7.7 years (interquartile range: 5.8 years). Nine (4.9%) of the 184 infants were subsequently diagnosed with strabismus at a mean age of 4.5 years (range: 1.3 to 8.7 years) (7 with esotropia and 2 with exotropia).
conclusionPseudostrabismus is a relatively frequent diagnosis in the first year of life. The prevalence of strabismus among infants with pseudostrabismus in this cohort was lower than those in previous reports and similar to strabismus rates reported in the same population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.